• Home
  • Search Results

Research Studies

UNC-Chapel Hill Division of Pulmonary Diseases and Critical Care Medicine

34 studies match your search
Not currently enrolling

COPD Study of Two Drugs

This is a research study to find out if Azithromycin or Roflumilast, medicines used in COPD, works better for people with Chronic Obstructive Pulmonary Disease (COPD).

Age & Gender
  • 40 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Not currently enrolling

COPD Registry

Researchers are looking for current and former smokers with or without COPD to enroll in a registry to be contacted for future studies.

Age & Gender
  • 40 years ~ 99 years
  • Male, Female
Study Interest
  • Behavior
  • Lungs and Breathing
  • Substance Use (tobacco, alcohol, opioids, etc)
By physician referral or invitation only

Elevate Remote CF Care

Hypothesis: The development of patient-focused tools and care processes will enable a transition from predominantly office-based CF care to a more convenient, co-produced model. The increased utilization of remote care will be associated with improved adherence to disease monitoring and complication screening guidelines and will increase patient satisfaction. Specific Aims: 1. Customize a patient-facing smartphone application (Nudge) designed to "coach" each patient toward a co-produced goal of convenient and effective health monitoring within the context of enhanced remote care. 2. Develop care processes that facilitate monitoring of respiratory status at home, using home spirometry and remote sputum collection, that include education, electronic reminders, and specimen collection/shipping supplies 3. Implement care processes that allow convenient access to necessary screening procedures, using the Nudge application to provide well-timed electronic reminders and track performance of screening tests.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Genetics and Genetic Disorders
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Open-label Extension Study of Seralutinib in Adult Subjects with PAH

The purpose of this trial is to allow patients who are currently on the PROSERA trial to receive medication until the study drug is commercially available.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Pressure
  • Genetics and Genetic Disorders
  • Lungs and Breathing
  • Rare Diseases
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Idiopathic Pulmonary Fibrosis (IPF) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (ILD) Registry

This registry will collect data on the strategies used to achieve a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (ILD) and the treatment and management efforts applied throughout study follow-up, clinical outcome events and patient reported outcome data. Blood samples will be collected periodically throughout the study for use in future research efforts. For participants with non-IPF, chronic fibrosing ILD with progressive phenotype, HRCT images will be collected throughout the study for use in future research efforts.

Age & Gender
  • 40 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
  • Rare Diseases
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

STOP PEDS Xenon MRI Ancillary Study

Evaluate the regional lung function and structural changes using MRI in children with cystic fibrosis (CF) prescribed either immediate or tailored therapy for their pulmonary exacerbation. The primary outcome measure for this ancillary study is the change in ventilation defect percentage (VDP) calculated from Xe MRI, which represents the fraction of the lung with absent or reduced ventilation.

Age & Gender
  • 6 years ~ 18 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Genetics and Genetic Disorders
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Pediatric Cystic Fibrosis Exacerbation Study

Evaluate the differences between two different treatment durations for exacerbations in a pediatric sample to determine which should be clinical standard.

Age & Gender
  • 3 years ~ 18 years
  • Male, Female, Gender Inclusive
Study Interest
  • Genetics and Genetic Disorders
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Medication Frequency for Infected Pleural Fluid

We are performing a clinical study to determine the optimal frequency for medications for infected pleural fluid, referred to as intrapleural enzyme therapy (IET). Participants will either receive once daily IET or twice daily IET. We hypothesize that once daily IET will be non-inferior to twice daily IET.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Immune System/Infections
  • Lungs and Breathing
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

PROMOTING ACCESS TO CREATE HOPE and HEALING

We are looking for links between cystic fibrosis outcomes and a history of intimate partner violence.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

International Severe Asthma Registry

Gather detailed information on the health and treatment of patients with severe asthma worldwide, track how well patients are responding to treatment, and undertake medical research using data from the registry to improve asthma treatment and care.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Lungs and Breathing
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research